Laboratory corporation of america holdings (LH)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09Sep'08
Revenue, Net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,294

9,191

9,028

8,505

3,192

2,474

1,772

6,011

10,516

10,427

10,379

5,808

5,776

5,733

5,689

5,671

5,632

5,617

5,597

5,542

5,471

5,343

5,178

5,003

4,873

4,782

4,732

4,694

4,664

0

0

0

Reimbursement Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

219

224

226

174

118

71

20

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues

11,587

11,554

11,388

11,291

11,276

11,333

11,290

11,080

10,742

10,308

9,902

9,696

9,598

9,552

9,513

9,416

9,254

8,680

3,311

2,545

1,793

6,011

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,161

6,082

5,973

5,602

2,169

1,645

1,147

3,808

6,647

6,581

6,524

3,585

3,541

3,490

3,443

3,421

3,370

3,343

3,314

3,267

3,216

3,129

3,019

2,906

2,829

2,767

2,744

2,723

2,708

0

0

0

Cost of Reimbursable Expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

219

224

226

174

118

71

20

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of Revenue

8,396

8,302

8,184

8,114

8,089

8,157

8,069

7,865

7,584

7,216

7,166

6,955

6,809

6,698

6,380

6,306

6,199

5,776

2,288

1,716

1,168

3,808

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross Profit

3,190

3,252

3,204

3,176

3,187

3,176

3,221

3,215

3,158

3,091

2,736

2,740

2,789

2,854

3,133

3,109

3,055

2,903

1,022

829

625

2,203

3,869

3,845

3,854

2,223

2,235

2,243

2,245

2,249

2,261

2,273

2,282

2,274

2,254

2,213

2,159

2,097

2,044

2,014

1,988

1,970

1,956

0

0

0

Selling, general and administrative expenses

1,626

1,624

1,607

1,587

1,567

1,570

1,591

1,590

1,553

1,499

1,203

1,222

1,274

1,345

1,633

1,619

1,600

1,628

608

528

436

1,198

2,093

2,066

2,049

1,128

1,121

1,128

1,126

1,114

1,106

1,104

1,148

1,159

1,161

1,148

1,071

1,034

1,002

979

971

958

945

0

0

0

Amortization of Intangible Assets

248

243

235

228

226

231

238

238

231

216

202

188

182

179

174

178

177

164

80

53

31

76

138

140

138

81

83

84

84

86

84

84

85

85

84

81

77

72

69

67

64

62

60

0

0

0

Asset Impairment Charges

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net restructuring and other special charges

59

54

60

55

54

48

42

54

81

70

74

75

43

58

102

106

113

113

52

31

19

17

29

27

32

21

38

39

36

25

15

34

49

80

69

48

30

12

16

12

22

13

27

0

0

0

Operating Income (Loss)

819

1,330

1,301

1,305

1,338

1,325

1,348

1,331

1,292

1,305

1,256

1,253

1,289

1,270

1,222

1,206

1,163

996

281

215

138

910

1,607

1,610

1,633

990

991

991

998

1,023

1,055

1,050

999

948

939

935

980

978

955

955

929

935

922

0

0

0

Other income (expenses):
Interest expense

239

240

234

233

237

244

253

254

246

235

220

218

217

219

223

220

225

274

166

136

104

109

185

184

181

96

99

99

97

94

89

85

85

87

186

144

108

70

60

67

65

62

-65

0

0

0

Equity method income, net

0

9

11

11

12

11

9

10

11

11

12

11

8

7

8

7

8

10

0

1

2

14

26

26

26

16

16

17

21

21

20

17

12

9

4

6

8

10

15

15

14

13

14

0

0

0

Investment income

10

8

8

8

7

7

4

2

2

2

1

1

1

1

2

1

1

1

0

0

0

1

1

3

3

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

2

0

0

0

Other, net

-8

-3

-59

147

160

167

210

-3

-6

-6

6

4

2

12

-4

-2

-2

-7

-11

-8

1

10

16

21

13

2

2

-1

-7

-7

-10

-12

-6

-5

-3

-3

-4

-4

-4

-4

-3

-3

-2

0

0

0

Earnings before income taxes

582

1,104

1,026

1,238

1,281

1,268

1,320

1,087

1,053

1,077

1,056

1,052

1,085

1,073

1,004

992

947

726

104

72

38

826

1,466

1,477

1,494

915

912

909

916

944

977

970

922

866

857

853

906

915

902

909

881

884

871

0

0

0

Provision for income taxes

260

280

270

384

384

384

-95

-183

-168

-155

349

340

353

360

345

358

347

287

55

40

35

314

547

547

554

340

343

340

345

359

375

379

357

333

327

318

340

344

320

335

325

329

346

0

0

0

Net earnings

322

824

755

853

897

883

1,415

1,271

1,222

1,232

707

712

731

712

658

634

599

438

49

31

3

512

918

929

940

575

569

568

570

584

602

591

564

533

530

535

566

571

582

573

556

555

524

0

0

0

Less: Net earnings attributable to the noncontrolling interest

1

1

1

1

1

0

2

4

4

5

3

1

1

1

1

1

1

1

0

0

0

1

2

2

2

1

1

1

1

1

4

7

10

13

13

13

13

13

13

13

12

12

12

0

0

0

Net Income (Loss) Attributable to Parent

321

823

754

852

896

883

1,413

1,266

1,217

1,227

703

711

730

711

657

632

598

437

49

31

3

511

916

927

937

573

567

567

568

583

598

584

554

519

516

521

552

558

569

560

543

543

512

0

0

0

Basic earnings per common share (in dollars per share)

-3.27

-

2.26

1.94

1.88

-

3.14

2.29

1.70

-

1.68

1.80

1.79

-

1.74

2.00

1.61

-

1.53

1.69

0.04

-

1.62

1.67

-

-

1.66

1.65

1.58

-

1.56

1.59

1.66

1.37

1.34

1.22

1.27

1.30

1.37

1.48

1.27

1.35

1.22

1.26

1.23

1.02

Diluted earnings per common share (in dollars per share)

-3.27

-

2.25

1.93

1.86

-

3.10

2.27

1.67

-

1.65

1.78

1.75

-

1.71

1.96

1.58

-

1.50

1.66

0.04

-

1.59

1.64

-

-

1.63

1.62

1.56

-

1.53

1.56

1.63

1.37

1.31

1.20

1.23

1.24

1.34

1.46

1.25

1.31

1.21

1.24

1.22

1.00

Previous Accounting Guidance [Member]
Gross profit, as reported

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss), including portion attributable to NCI, as reported

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) attributable to Parent, as reported

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of Revenue

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative expenses

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for income taxes

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less: Net earnings attributable to the noncontrolling interest

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic earnings per common share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

1.77

1.84

1.87

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted earnings per common share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

1.74

1.82

1.84

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-